# Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

> **NCT00002980** · PHASE1 · COMPLETED · sponsor: **California Cancer Consortium**

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** decitabine

## Key facts

- **NCT ID:** NCT00002980
- **Lead sponsor:** California Cancer Consortium
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002980, "Decitabine in Treating Patients With Melanoma or Other Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*